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Introduction: Nestin-expressing cells isolated from different human tissues reveal self-renewal capacity and a
multilineage differentiation potential. In particular, adult stem/progenitor cell populations from exocrine glands
such as the pancreas, salivary gland and sweat gland are characterized by prominent nestin expression.
Interestingly, human mammary gland histological examinations also demonstrated the existence of nestin-positive
cells in the ductal compartments. Within the scope of our previous work we wonder whether an isolation of
nestin-positive cell populations from human mammary gland biopsies is possible and what characteristics they
have in vitro. Cell populations from both sexes were propagated and subjected to a comparison with other
gland-derived cell populations.
Methods: Human mammary tissue biopsies were mechanically and enzymatically treated, and the isolated acini
structures were observed with time-lapse microscopy to track adherently outgrowing cells. The proliferation
potential of the cell population was assessed by performing growth curves. On the gene and protein levels we
investigated the expression of stem cell markers as well as markers indicating multilineage differentiation.
Results: We succeeded in establishing proliferating cell populations from breast tissue biopsies of both sexes. Our
results display several similarities to the glandular stem cell populations from other exocrine glands. Beside their
proliferation capacity during in vitro culture, the obtained cell populations are characterized by their prominent
nestin expression. The cells share surface proteins commonly expressed on adult stem cells. We demonstrated the
expression of stem cell-related genes like Oct4, Sox2, KLF4 and Nanog, and confirmed multipotent differentiation
capacity by detecting transcripts expressed in endodermal, mesodermal and ectodermal cell types.
Conclusion: With this study we present an efficient procedure for isolation and propagation of nestin-positive stem cells
obtained from male and female breast tissue, which is frequently available. The established multipotent cell populations
could be easily expanded in vitro and thus hold promise for cell-based therapies and personalized medicine.
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Potential stem/progenitor cell populations in the mam-
mary gland were the subject of a variety of research pro-
jects with the aim to understand gland development,
maturation, lactation as well as tumor formation. Owing
to the constant evolution of new techniques for analysis,
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reproduction in any medium, provided the orabout mammary stem/progenitor cells increased con-
tinuously over the years. To understand the behavior of
adult stem cells in vivo and in vitro, it is necessary to ad-
dress briefly the normal human gland development, with
a focus on the key mechanisms that are thought to be
important in human and rodents.
The embryonic mammary placodes contain ectodermal
epithelium (keratin (K)14-positive) involuted into meso-
dermal stroma. The so-called mammary bud is filled with
multipotent progenitors (K5-positive and K14-positive)
and forms until birth a small, less branched, resting glandLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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gland is established at that point by a basal K14-positive
and K5-positive myoepithelial layer and a luminal layer
synthesizing cytokeratins 8 and 19. A subpopulation of
K14-positive and K8-positive luminal cells is interwoven
into the luminal layer while fewer cells still synthesize K5.
In resting glands after complete juvenile development,
only K8/19-positive luminal cells and K14/15-positive
myoepithelial cells exist [1-4].
The mammary gland maturation during puberty in-
cludes the formation of so-called terminal end buds at
the tips of the branches. The main signaling for this
event is mediated by hormones (for example, endothelial
growth factor) and estrogen [5]. The terminal end buds
consist of body cells enveloped by cap cells. The latter
are thought to be a tissue-specific type of stem/progeni-
tor cell and the source of luminal epithelial cells and
myoepithelial cells [5]. Both cell types form in a typical
epithelial fashion the hollow branches of the mammary
gland that extend up to the nipple conducting the milk.
During pregnancy and lactation the mammary gland
sprouts extensively into the breast connective tissue. For
milk secretion, lobular cells at the ends of the branches
form secretory acinar structures and transform to alveolar
cells producing milk proteins [5,6]. These luminal cell-
derived milk producing cells synthesize K8 and K19 [1].
The enormous tissue expansion during pregnancy
somehow needs proliferative active cell populations,
which ensure endogenous tissue formation in adulthood.
There is still controversy about the existence of uni-
potent, bipotent or multipotent stem cells in mammary
gland tissue [1-3].
The existence and isolation of stem cells in mammary
glands was described by several groups starting decades
ago. In 1959 Deome and colleagues described mice trans-
plantation studies of mammary tissue into body sites freed
of this tissue, resulting in a successful reestablishment of
mammary outgrows [2]. In 1988 the identification of
label-retaining cells in mammary explant cultures from
mouse using thymidine labeling was demonstrated by
Smith and Medina [7]. The isolation of tissue-resident
stem cells is nowadays commonly performed by enzym-
atic digestion and/or by flow cytometric isolation of
subpopulations using surface markers. For instance,
Shackelton and colleagues demonstrated the isolation of
Lin–CD29hiCD24+ cells from mouse mammary tissue
and their power to reconstitute a complete mammary
gland in cleared mammary fad pads, even when they
transplanted just one cell [3]. Eirew and colleagues re-
vealed a CD49f+ and EpCAMneg-low phenotype for human
mammary repopulating units by investigating a subset of
cells that give rise to newly formed mammary glands
in serial transplantation experiments similar to those
performed in the 1950s [8].A relatively broad spectrum of potent surface markers
and their usage for isolation of stem/progenitor cells from
mammary glands via cell sorting has been investigated
and discussed in the literature [1,3,9-13]. Prominent can-
didates such as Sca-1, EpCAM, CD14, CD24, CD29,
CD49f and CD61 for mouse and human mammary stem
or progenitor populations were reviewed by Stingl and
colleagues in 2006 [10]. In congruence with the earlier
mentioned native developmental function, these results of
transplantation studies with certain mammary stem cell
subpopulations indicated their multipotency by giving rise
to mammary committed progenitors with progeny of dif-
ferent fates [8,9,11,13-15]. To clarify this cellular plasticity,
various in vitro assays of mammary-derived cell popu-
lations had been performed. First insights into the cha-
racteristics and behavior of isolated mammary stem cells
in vitro were gained from adherent two-dimensional
cultures or from suspension cultures; for example, as
mammospheres. The focus of gene and protein expression
analysis for those studies was chosen for surface markers
and/or cytokeratin synthesis, to classify the state of differ-
entiation in comparison with histological data [11,13-21].
The results demonstrated that the mammary stem cells
preserve their capability for differentiation into mammary
cells and retain the sensitivity against tissue-specific
hormones [16,22]. On the contrary, their continuous pro-
liferation and the expression of stem cell and prolifera-
tion-related markers such as Ki67, musashi-1, Sca-1 or
p21 affirmed that they keep a stem/progenitor state
[11,13-18]. Interestingly, even the isolation and cultiva-
tion of stem cells from human breast milk has been
documented [19-21]. Hassiotou and colleagues recently
demonstrated the isolation of cell populations from hu-
man breast milk, which expressed stem cell-related tran-
scription factors such as Oct4, Sox2 and Nanog and
proved their multilineage differentiation potential [19].
A less popular marker for the characterization of
mammary stem cells is nestin, which has been expressed
in cells of the mammary gland [23,24]. The expression
of the intermediate filament nestin has already been
shown to be associated with multipotency and stemness
of several cell populations [25]. We and others demon-
strated that different glandular tissues (for example, pan-
creas, salivary glands or sweat glands) yield nestin-positive
stem cell populations with multipotent, long-term prolif-
erative potential in vitro [26-31]. There is thus strong evi-
dence that stem cells in glandular tissues seem to have
common characteristics and are hallmarked by their
prominent nestin expression. All of these scientific results
regarding the mammary gland are of paramount import-
ance, as they unravel the basic principles of glandular de-
velopment and homeostasis [20,21].
In view of an analogous embryonic gland development
for mammary glands and sweat glands from ectodermal
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comparable characteristics between the isolated cell pop-
ulations in vitro [32]. Hence, we applied isolation proce-
dures and propagation methods for the harvesting of
mammary stem cells similar to those we have already
established for pancreatic, submandibular or sweat
gland-derived stem cells [26,29,33]. We opted to isolate
stem cells from the mammary tissue of female and male
donors via adherence to conventional cell culture plastic,
similar to the methods we used for the other glandular
stem cells and also similarly applied by Cregan and col-
leagues for breast milk-derived stem cells [21]. To our
knowledge we demonstrate here for the first time a
method for the isolation and propagation of nestin-
positive mammary gland-derived stem cells and present
an initial characterization of the cell populations derived
from both genders. This may foster the insights regarding
mammary stem cells and can offer a relatively easy access-
ible source for (autologous) adult stem cell applications.
Materials and methods
Breast tissue biopsy collection
We received postoperative samples in conventional
Ringer solution on ice and harvested them within 12
hours after tissue removal from the patient. All samples
derived from breast or abdominal reduction surgeries
(male patients) without pathological phenotype. Exclud-
ing the isolation establishment period, we were able to
generate stable cell populations meanwhile from five fe-
male and three male donors up to passage 22 with the
final standard protocol. The experiments of this study
were performed with mammary gland-derived cells
(MGDCs) from four different donors: MGDC 1, female
patient, 47 years old; MGDC 2, male patient, 18 years old;
MGDC 3, female patient, 40 years old; and MGDC 4,
female patient, 50 years old. All experiments were
performed according to Helsinki guidelines, in compliance
with national regulations for the experimental use of hu-
man material. Utilization of human biopsies for research
purposes was approved by the ethics committee of the
University of Luebeck (reference number 10–058). All pa-
tients gave written informed consent.
Isolation of acinary structures from human mammary tissues
During isolation we excised the small, pearl-like struc-
tures (diameter <2 mm) embedded in the mesenchymal
parts of human breast tissue using forceps and scalpels.
We manually freed them from adjacent fat and subse-
quently dissected and digested them using the patented
method as described previously by Kruse and colleagues
[27,28]. Briefly, after an initial mechanical dissection
with scissors, the tissue was treated twice (20 and 15 mi-
nutes) with digestion medium containing HEPES–Eagle
medium (pH 7.4), 10 mM HEPES buffer, 70% (v/v)modified Eagle’s medium, 0.5% (v/v) Trasylol (Bayer AG,
Leverkusen, Germany), 1% (w/v) bovine serum albumin
(PAA, Cölbe, Germany), 2.4 mM CaCl2 and collagenase
(0.63 PZ/mg; Serva, Heidelberg, Germany) at 37°C. Prior
to each digestion, the preparation mixture was gas-
flushed with a mixture of oxygen and carbon dioxide
(95% v/v). Between the two digestion steps, the tissue
pieces were washed with isolation medium, being equal
to digestion medium but lacking collagenase. Further
processing was done by mechanical mincing using small
chirurgic scissors. After the second digestion step, the
remaining tissue fragments were dissociated by up-and-
down suction through different glass pipettes with pro-
gressively more restrictive orifices (10, 5 and 2 ml pi-
pettes) and filtered through a nylon mesh (250 μm) to
exclude tissue debris. The acini-containing suspension
was finally centrifuged for 5 minutes at 150 × g and the
pellet was resuspended in DMEM (Invitrogen, Darmstadt,
Germany) with 20% (v/v) FCS (PAA, Cölbe, Germany)
and penicillin/streptomycin (PAA, Cölbe, Germany). The
acini-containing medium was seeded into one well of a
six-well cell culture test plate (TPP, Trasadingen,
Switzerland) and this primary culture was incubated for
2 days in a humidified incubator with 37°C and 5% CO2
in the atmosphere. After 2 days the first media ex-
change was performed and the cultivated cells were
propagated until highly confluent colonies were visible.
Cultivation of mammary cells
The cultivation after the first trypsinization was per-
formed with DMEM with 10% (v/v) FCS and penicillin/
streptomycin in TPP cell culture plastic. We generally
used polystyrene-plastic dishes as delivered (all cell cul-
ture treated by the supplier TPP). The incubator settings
were the same as already described. When the popula-
tion reached a confluence of >80% covered growth area,
it was split in a ratio of 1:3 regarding the growth area by
standard trypsinization. This includes the removal of the
old medium, one washing step with PBS (Invitrogen,
Darmstadt, Germany) and incubation for 2 minutes at
37°C after adding the Trypsin–ethylenediamine tetraacetic
acid mixture (PAA, Cölbe, Germany). By microscopic
control of the cell’s detachment, the stopping procedure
starts by adding the doubled volume media to the trypsin-
based suspension. The whole liquid was afterwards
centrifuged at 180 × g for 5 minutes and the pellet was
resuspended with cultivation medium. The cells were then
reseeded to new cell culture plastics.
Cell counting and growth curve
For determination of cell numbers, we trypsinized the
cells and centrifuged them as described above. The
resuspended pellet was then diluted with lysis buffer
and stabilization buffer according to the manufacturer’s
Table 1 Antibodies used for flow cytometric analysis
Antigen Host and clonality Label Catalogue number
CD9 Mouse IgG1κ Phycoerythrin 555372
CD15 Mouse IgG1κ PerCP-Cy5.5 560828
CD29 Mouse IgG1κ Phycoerythrin-Cy5 559882
CD31 Mouse IgG1κ Phycoerythrin 555446
CD44 Mouse IgG1κ Phycoerythrin 555479
CD81 Mouse IgG1κ Phycoerythrin 555676
CD105 Mouse IgG1κ PerCP-Cy5.5 560819
None Mouse IgG1κ Phycoerythrin 555749
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the cell suspension was measured with a Nucleocounter
(ChemoMetec, Allerød, Denmark). To perform growth
curves we seeded 50,000 cells per well in DMEM
(Invitrogen, Darmstadt, Germany) with 10% (v/v) FCS
(PAA, Cölbe, Germany) and penicillin/streptomycin in
six six-well cell culture plates, using three wells of each
plate (n = 3). At days 1, 3 and 5 the medium of one six-
well plate was removed and cells were trypsinized as de-
scribed before. Afterwards, 50 μl samples were mea-
sured using the Nucleocounter (ChemoMetec, Allerød,
Denmark) and the arithmetic average was calculated.None Mouse IgG1κ Phycoerythrin-Cy5 555750
None Mouse IgG1κ PerCP-Cy5.5 550795
All antibodies from Becton Dickinson (Becton Dickinson, Heidelberg, Germany).
PerCP, peridinin chlorophyll protein.Time-lapse microscopy
The initially isolated acini were examined using time-
lapse microscopy according to settings described in
Rapoport and colleagues [30]. Briefly, we seeded an ali-
quot of the acini-containing suspension in a well of a
six-well plate and cultivated the plate inside the culture
chamber combined with an Olympus ix81 microscope
(Olympus, Hamburg, Germany). Every 7.5 minutes a
phase-contrast picture of the acini was taken automatic-
ally using 100× total magnification.Flow cytometry
For flow cytometry the cells were trypsinized, counted and
pelleted according to the previously described cultivation
protocol. Subsequently, they were resuspended in ice-cold
fluorescent-activated cell sorting buffer containing 1% hu-
man normal immunoglobulin (Privigen; CSL Behring,
Hattersheim am Main) diluted in PBS. The cell suspension
was apportioned in 100,000 to 150,000 cells per well in a
96-well plate for all desired antibodies, isotype and negative
controls. The whole subsequent procedure was performed
on ice or in a cooled centrifuge. The plates were then
centrifuged in an Allegra®X-15R centrifuge (Beckmann
Coulter, Krefeld, Germany) for 5 minutes at 200 × g for ac-
cumulation of the cells on the well bottom. Subsequently
the blocking was performed with pure immunoglobulin for
1 to 2 minutes and the primary-labeled antibodies (Table 1)
were added to the blocking solution in adequate volumes to
reach a final concentration of 10 μg/ml for each antibody.
After incubation for 1 hour on ice, the cells were washed
twice with fluorescent-activated cell sorting buffer alter-
nating with a centrifugation step and resuspension in buf-
fer. An immediate measurement of the fluorescence
intensities was then performed with a FACS Calibur flow
cytometer (Becton Dickinson, Heidelberg, Germany) and
the according CellQuestPro Software (Becton Dickinson,
Heidelberg, Germany). For standardization the isotype
controls were gated with a cross gate and the tests were
analyzed using this gate and calculating the positive events
by subtraction of the quadrant statistics.Polymerase chain reaction
MGDCs of the appropriate passage were cultured in a
petri dish and when they reached a confluence of ap-
proximately 80% they were washed once with PBS.
After removal of PBS they were scraped with a cell
scraper (TPP, Trasadingen, Switzerland) in 2 ml fresh
PBS, pelleted by centrifugation for 5 minutes at 180 × g
and the pellet was stored at −80°C until analysis. The
isolation of the total RNA was performed using an
RNeasy Plus mini Kit and the automated sample prep-
aration system QIAcube (both QIAGEN, Hilden,
Germany) according to the manufacturer’s protocols.
The concentration of eluted RNA was measured using
a NanoDrop Spectrophotometer ND-1000 (Peqlab,
Erlangen, Germany). Subsequently 1 μg total RNA was
used for reverse transcription with a QuantiTect re-
verse transcription kit (QIAGEN, Hilden, Germany) in-
cluding a genomic DNA digestion step.
The following polymerase chain reaction was
performed as duplicates with 1 μl cDNA for each primer
in a 25 μl reaction volume of QuantiFast SYBR Green
PCR kit (QIAGEN, Hilden, Germany) using a RealPlex2
thermocycler (Eppendorf, Hamburg, Germany). The
primers (QuantiTect Primer Assays) are all commer-
cially available and validated by QIAGEN (Table 2).
Some primers are intron-spanning for exclusion of gen-
omic transcripts in the electrophoresis. For visualization
and quality control of the generated amplicons we used the
capillary gel electrophoresis system QIAxcel (QIAGEN,
Hilden, Germany). A quantitative analysis of the expression
intensity of selected relevant transcripts was evaluated with
regard to the housekeeping gene β-actin. The cycle thresh-
old mean of duplicate samples for the analyzed transcript
was calculated and set in relation to the cycle threshold
mean of the housekeeping gene (cycle threshold mean of
β-actin/cycle threshold mean of specific transcript).
Table 2 List of used primers
Amplified transcript QuantiTect Primer Assay
β-Actin Hs_ACTB_1_SG QuantiTect Primer Assay (200)
c-Myc Hs_MYC_1_SG QuantiTect Primer Assay (200)
Oct4 Hs_POU5F1_va.2_SG SG QuantiTect Primer Assay (200)
Klf4 Hs_KLF4_1_SG QuantiTect Primer Assay (200)
Sox2 (sex determining region Y –box 2) Hs_SOX2_1_SG QuantiTect Primer Assay (200)
Nanog Hs_NANOG_2_SG QuantiTect Primer Assay (200)
CD 9 Hs_CD9_1_SG QuantiTect Primer Assay (200)
Nestin Hs_NES_2_SG QuantiTect Primer Assay (200)
Ki-67 Hs_MKI67_1_SG QuantiTect Primer Assay (200)
MEF2D (myocyte enhancer factor 2D) Hs_MEF2D_2_SG QuantiTect Primer Assay (200)
α SMA (alpha-smooth muscle actin) Hs_ACTA2_1_SG QuantiTect Primer Assay (200)
PPARγ (peroxisome proliferator-activated receptor gamma) Hs_PPARG_1_SG QuantiTect Primer Assay (200)
SPP1 (secreted phosphoprotein 1) Hs_SPP1_1_SG QuantiTect Primer Assay (200)
VWF (von Willebrand factor) Hs_VWF_1_SG QuantiTect Primer Assay (200)
CK18 (cytokeratin 18) Hs_KRT18_1_SG QuantiTect Primer Assay (200)
NF_l (neurofilament light chain) Hs_NEFL_1_SG QuantiTect Primer Assay (200)
NF_m (neurofilament medium chain) Hs_NEFM_1_SG QuantiTect Primer Assay (200)
NF_h (neurofilament heavy chain) Hs_NEFH_1_SG QuantiTect Primer Assay (200)
Enolase (neuron-specific enolase) Hs_ENO2_1_SG QuantiTect Primer Assay (200)
PGP 9.5 (protein gene product 9.5) Hs_UCHL1_1_SG QuantiTect Primer Assay (200)
β3-Tubulin Hs_TUBB3_1_SG QuantiTect Primer Assay (200)
MAP2 (microtubule-associated protein 2) Hs_MAP2_1_SG QuantiTect Primer Assay (200)
All primers from QIAGEN (Hilden, Germany).
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The cells were washed once with PBS and fixed with
methanol:acetone (7:3, v/v; both Carl Roth, Karlsruhe,
Germany) and 1 mg/ml 4′, 6-diamidino-2-phenylindole
(Roche, Mannheim, Germany) for 5 minutes at room
temperature. After three washing steps with PBS they
were blocked using 16.5 μl/ml normal goat serum (Vec-
tor Laboratories Ltd, Peterborough, UK) in PBS for 20
minutes at room temperature. The blocking mixture was
then removed and the primary antibodies diluted in Tris-
buffered saline Tween-20 buffer with 1% (w/v) BSA were
added and incubated in a humidified chamber overnight at
4°C in a moist chamber. Primary antibodies raised against
human nestin (mouse, monoclonal; Abcam, Cambridge,
UK), Ki67 (rabbit, polyclonal; Abcam, Cambridge, UK),
cytokeratin 19 (mouse, monoclonal; Sigma Aldrich,
Taufkirchen, Germany), neurofilament light, medium and
heavy chains (1:1:1 mixture, rabbit, polyclonal; AbD
Serotec, Düsseldorf, Germany) and alpha-smooth muscle
actin (mouse, monoclonal; Dako, Hamburg, Germany)
were applied. After incubation, three washing steps were
performed and the secondary antibodies were incu-
bated under the same conditions as the primary ones.Secondary antibodies were Cy3-labeled goat-anti-mouse
and fluorescein-labeled goat-anti-rabbit (both Dianova,
Hamburg, Germany). After incubation for 1 hour at 37°C
in a wet chamber, the secondary antibodies were removed
by three washing steps with PBS and one rehydration step
with distilled water. Samples were afterwards mounted
with Roti-Mount Fluorocare mounting medium (Carl
Roth, Karrlsruhe, Germany).
Immunhistochemistry
Breast tissue was cut into a small piece of 0.5 cm edge
length directly after delivery. After a brief rinse in fresh
ice-cold PBS, the tissue was fixed for 1 hour in 4% (w/v)
paraformaldehyde (Merck, Darmstadt, Germany) in PBS
at 4°C. Subsequently the tissue was embedded in a hand-
made aluminum foil cube filled with OCT Tissue-Tek
(Sakura, Alphen aan den Rijn, The Netherlands) and dir-
ectly frozen at −80°C. For slicing we used a Cryotome
(HM 560; Thermo Fisher Scientific, Schwerte, Germany)
and prepared 5 μm thick slices, which were mounted on
Menzel Superfrost Plus Gold slides (Menzel, Braunschweig,
Germany). The subsequent storage until staining was
at −20°C.
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above. Initially the mounting media was rinsed away in
distilled water for 2 minutes. Then the slice was fixed
again with 4% paraformaldehyde solution for 5 minutes at
room temperature. After three washing steps with PBS
(each 5 minutes), the slices were encircled with a PAP
hydrophobic barrier pen (Abcam, Cambridge, UK) and
the blocking mixture was added to the circle’s center after
drying of the line. The blocking procedure was performed
for 20 minutes at room temperature, followed by incuba-
tion with the first antibody against human nestin (mouse,
monoclonal; (Abcam, Cambridge, UK) overnight at 4°C in a
moist chamber. After rinsing three times with PBS the sec-
ondary antibody, Cy3-labeled goat-anti-mouse (Dianova,
Hamburg, Germany), was added and incubated for another
hour under the same conditions. The subsequent three
washing steps with PBS include in the first step incubation
with 1 mg/ml 4′, 6-diamidino-2-phenylindole (Roche,
Mannheim, Germany) for 5 minutes at room temperature.
Finally, we rinsed the specimens in distilled water and
mounted them using Roti-Mount Fluorocare mounting
medium (Carl Roth, Karlsruhe, Germany).
Results and discussion
Mammary-residing nestin-positive cells can be isolated
from tissue of both sexes
The immunohistological examination of human frozen
mammary tissue sections using a human specific anti-
nestin-antibody revealed nestin-positive cells within the
glandular structures. The majority of positive cells were
observed in the peripheral layer of myoepithelial cells
(Figure 1A). The localization of nestin-positive cells
in the myoepithelial layer of mammary glands was previ-
ously described by Li and colleagues and Kolar and col-
leagues [23,24].
We were able to isolate cells from this tissue and
propagate them over several passages (so far >20 pas-
sages) with maintenance of their nestin expressionFigure 1 Nestin expression in mammary tissue and derived cell popu
(B) in cultivated cells of mammary gland-derived cells (MGDC 3) after nine
antibody (red). Nuclear counterstaining with 4′ , 6-diamidino-2-phenylindo(Figure 1B). Cregan and colleagues have already published
the isolation of nestin-positive cells from human breast
milk [21]. Our observations revealed that the expres-
sion of nestin was not ubiquitous but in the majority
of cells comparable with Cregan and colleagues’ re-
sults. We were additionally able to demonstrate the
maintenance of this protein expression over several
passages. Interestingly, comparable findings from our
group concerning stem cells derived from the pan-
creas, salivary gland and sweat gland [26,27,29,33] re-
vealed nestin expression as a common feature of
gland-derived stem cells.
In view of these results we have to ask from which
part of the tissue these cells originate. The continuous
monitoring of the cell’s behavior during the outgrowth
with time-lapse microscopy should provide insights into
the acinar disintegration process, and consequently into
the growth behavior of outgrowing glandular cells. We
observed a continuous migration of cells out of the aci-
nar structure and their stringent connection to each
other as soon as they form a proliferating monolayer on
the cell culture plastic. Proliferation activity and active
movement was exclusively visible inside a sharp margin
formed by elongated cells in the periphery of the colonies
(Figure 2). After several days these colonies break up and
the cells spread over to the remaining growth area, con-
tinuing their proliferation (Figure 3 and Additional file 1).
For human pancreatic tissue a similar disintegration
process of acinary structures and the establishment of a
proliferating stem cell population were demonstrated by
Rapoport and colleagues [30]. They characterized the ap-
parent melting process of the acini with a fast migration
of the cells on the cell culture surface ongoing with a rapid
creation of a cell monolayer. Interestingly, no mitotic ac-
tivity could be detected in their initial cell population.
We observed for the acinary structures from mammary
glands a comparable process that shows one remarkable
difference: the outgrowing cells proliferate in a tightlations. Nestin-positive cells (A) in the female mammary gland and
passages. Nestin was stained using a mouse monoclonal anti-nestin
le (blue). Magnification: 200×. Bar = 100 μm.
Figure 2 Time-lapse microscopy of isolated mammary acinus. Time-lapse micrographs (interval: 6 hours) of primary mammary cells arising
from a single acinus. The lower panel (red dashed margin) illustrates the mitosis (interval: 7.5 minutes) at 54 hours indicated by the red arrow in each
picture. Magnification: 100 ×.
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breaks up after approximately 3 days and a slow emigra-
tion of singular but still proliferating cells was visible. So
far we have no complete explanation for this specialty. We
believe that this early process requires a tight intercellularFigure 3 Morphology of cultivated female and male mammary cell po
cells (MGDC 3) and (B) male mammary gland-derived cells (MGDC 2) beforconnection and communication between the cells. The
margin is probably formed by the first outgrowing cells
and cannot be maintained for longer than 3 days. Ultim-
ately, we generated a proliferating cell population, which is
also described for the other glandular stem cellpulations. Primary population of (A) female mammary gland-derived
e first passaging. Magnification: 50×. Bar = 100 μm.
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on the more detailed characterization to achieve closer in-
sights into the stem cell characteristics in comparison with
the previously described glandular stem cell populations.
This proof-of-concept trial will reveal the possibilties to
easily isolate adherently proliferating mammary cell popu-
lations with stem cell characteristics.Nestin-positive cells of both sexes proliferate adherently
in vitro
We succeeded in obtaining stably proliferating mam-
mary cell populations from male and female tissue do-
nors. The cells had a spindle-like shape and there were
no obvious differences with regard to morphology or
growth behavior between the cell populations of both
genders (Figure 3). The standardized propagation of the
mammary cells was so far possible until passage 22. For
the three MGDC populations we examined growth be-
havior by cell counting and calculated growth curves over
a time period of 5 days (Figure 4). After seeding, the cells
needed an adaption phase to adjust to the new environ-
ment and started with a phase of exponential growth
approximately at day 3. The population size grows con-
tinuously and we estimated a population doubling time
during the exponential growth phase of approximately 2
days. We never observed multilayered growth or floating
colonies during the daily monitoring of the cultivation
routine. This observation indicates a healthy, contact-
inhibited and anchorage-dependent population.Figure 4 Growth of mammary gland-derived cell populations in vitro.
populations (MGDC 1, MGDC 3) and one male (MGDC 2) cell population in
of triplets was calculated for each cell population and time point (n = 3).Nestin-positive cells of both sexes have a phenotype
comparable with other glandular stem cells
To classify the novel mammary cell population regarding
their cell surface protein expression we additionally
performed a flow cytometry analysis for one male sample
(MGDC 2) and two female samples (MGDC 1 and MGDC
3) in passages 6 and 12. We selected different antibodies
classically used in phenotypization of mesenchymal stem
cells, which were also applied for characterization of
gland-derived stem cells from the pancreas and salivary
gland [26]. Similarly to Gorjup and colleagues, we
obtained positive results for CD9 (tetraspanin-29), CD29
(integrin β1), CD44 (hyaluronan receptor), CD81 (TAPA-1)
and CD105 (endoglin) [26] (Additional file 2). We observed
for all populations and all passages qualitatively the same
marker expression. Quantitatively, varying amounts of
positively stained cells between the two passages 6 and 12
showed the same tendencies for all individuals.
Comparing the different individuals in each passage, a
qualitative difference for the protein detection was obvi-
ous. As the donors’ sexes and ages differ, we assume that
this is due to variable quantities of different phenotypic
subpopulations (Figure 5). Nevertheless, we were able to
show the common general expression of the positive
surface antigens for each population of male and female
individuals. The antigens CD15 (fucusyltransferase 4)
and CD31 (PECAM-1) were not detectable or were <1%
and thus were considered absent. The constitutive high
yield of cells positive for CD9, CD29 and CD81 indicates
the existence of stem cells in our populations, as alsoGrowth curves of two female mammary-gland-derived cell
passage 7 over a cultivation period of 5 days. The mean cell amount
Figure 5 Phenotypization of mammary gland-derived cell populations. Analyses were performed with mammary gland-derived cell
populations from three donors (MGDC 1, MGDC 2, MGDC 3) in passages (P) 6 and 12. The quantification of positive events for CD9, CD29, CD44,
CD81 and CD105 were calculated for each cell population to show possible variations between genders and individuals.
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colleagues [3,26]. The occurrence of CD44+ cells in all
populations points to the existence of possible migra-
tory, duct-forming cells [34]. We observed a reduction
in the amount of CD44+ cells over several passages.
Whether this is due to apoptosis or dedifferentiation,
transdifferentiation or normal differentiation is unratable
at the moment and could therefore also be associated
with a change in marker expression during in vitro cul-
ture. Notwithstanding, we assume that the cells do not
become neoplastic because this would have been indi-
cated through an upregulation of CD44 [34]. These ob-
servations support the findings of our proliferation
analysis, regarding a stable and healthy population.
The expression of endoglin (CD105) is reported in a
controversial context regarding mammary cells and
tissues. This marker is usually included in tumor for-
mation studies and indicates angiogenetic events be-
cause endoglin serves as a main surface protein for
(endothelial) cell invasion by binding of integrins.
Consequently, contrasting literature regarding en-
doglin synthesis by mammary cells exists describing
protumorigenic and antitumorigenic involvement of
this integrin-binding transforming growth factor beta
receptor [35,36]. Regarding our recent results, we pri-
marily reduce this information to the result that our
mammary cell populations express CD105 in the con-
text of in vitro cultivation for attachment to integrins.
Liao and colleagues described endoglin as an essentialmarker for isolation of murine mammary stem cells
that are able to form mammospheres. In the context of
the basal function of CD105 for cells, their findings
support our assumption because transplanted cells of
their mammospheres resulted in a reconstitution of the
mammary gland and not in tumor formation [37]. The
lack of CD15 and CD31 indicates that there are no im-
mune or endothelial cells present that may be a source for
CD105+ cells. The determined cell surface phenotype of
mammary cells in vitro seems to be comparable with
other propagable stem cells from different glands and is
similar to that of mesenchymal stem cells [26,38].
Nestin-positive cells show expression of markers
representative of the three germline layers
For characterization of the cell populations with regard to a
possible multipotent differentiation potential, we performed
a gene and protein expression analysis from MGDC 1,
MGDC 2 and MGDC 3 in passages 3 and 9 (n = 3). Using
real-time PCR we examined transcripts indicating stemness
(c-Myc, Oct4, Klf4, Sox2, Nanog, CD9, nestin) and prolifer-
ation (Ki67) as well as representative transcripts for
estimating spontaneous differentiation. We successfully
detected transcripts for all three embryonic germ layers
(endodermal: von Willebrand factor; mesodermal: MEF2D,
alpha-smooth muscle actin, PPARγ, SPP1; ectodermal:
cytokeratin 18, neurofilament-light chain, neurofilament-
medium chain, neurofilament-heavy chain, neuron-specific
enolase, PGP9.5, β3-tubulin, MAP2) (Figure 6). To
Figure 6 Expression analysis of gene transcripts from mammary gland-derived cell populations. Representative visualization of the
capillary gel electrophoretic analyses of detected amplicons in the propagated female mammary gland-derived cells (MGDC 1) from passage 9.
Expression of transcripts for the housekeeping gene β-actin (white), typical transcripts for stemness and proliferation (red) as well as for the
mesodermal lineage (blue), the endodermal lineage (yellow) and the ectodermal lineage (green) could be verified.
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female MGDC populations we quantitatively estimated the
expression intensity of selected relevant transcripts (nestin,
CD9, Ki67, cytokeratin 18, alpha-smooth muscle actin,
neurofilament-middle chain) of MGDC 1, MGDC 2 and
MGDC 3. Expression intensities fluctuate, but gross gene
expression of the three analyzed cell populations MGDC 1
to MGDC 3 was similar (Figure 7). In comparison with the
previous work of our group, this expression pattern is simi-
lar to those of human sweat gland-derived stem cells, sub-
mandibular gland-derived stem cells or the stem cell
populations isolated from the pancreas (Figure 8) [26,29].
Even though we analyzed a wider panel of markers we can
consider generally the mammary stem cells being similar to
the other glandular stem cell populations regarding the
common examined markers. The compared stem cellFigure 7 Quantitative real-time PCR analyses of relevant transcripts in
intensities of the analyzed transcripts for stemness (nestin, CD9), proliferatio
actin (αSMA), neurofilament (NF)-m) were calculated from cycle threshold v
gene (cycle threshold mean of β-actin/cycle threshold mean of specific trapopulations share the expression of genes for stemness,
proliferation and all three germ layer derivatives.
Within the scope of the results of the gene expression
analysis, we checked our cell population for multilineage
differentiation by immunocytochemical staining for sev-
eral typical proteins. We therefore compared female and
male cells, each in passages 3, 6 and 9, regarding their
protein expression referring to the transcripts found in
RT-PCR. All samples showed a distinct staining for
nestin (stemness), Ki67 (proliferation), cytokeratin 19
(stemness), neurofilament (neuronal differentiation) as
well as alpha-smooth muscle actin (mesodermal differ-
entiation). Other examined proteins (CK8, CK18, CK14,
Sox2, Oct4, Nanog, VWF, PPARγ, GATA4) showed a
fluctuating expression level and should be analyzed in
more detail in further experiments (data not shown).three mammary gland-derived cell populations. Expression
n (Ki67) and differentiation (cytokeratin (CK) 18, alpha-smooth muscle
alues (mean of duplicates) and set in relation to the housekeeping
nscript).
Figure 9 Immuncytochemical analysis of expressed proteins in mammary gland-derived cells. The staining for nestin (red), Ki67 (green),
cytokeratin19 (CK19, red), neurofilaments (NF, green) and alpha-smooth muscle actin (αSMA) are exemplarily shown for a female mammary
gland-derived cell population (MGDC 3, left panel) and a male mammary gland-derived cell population (MGDC2, right panel), each in passage 3
(left row of each panel) and passage 9 (right row of each panel). Nuclei are stained blue with 4′,6-diamidino-2-phenylindole. Bar = 100 μm.
Magnification: 200 ×.
Figure 8 Comparison of human gland-derived stem cells. Table of the comparative gene expression analysis of mammary gland-derived cells
(MGDCs) with glandular stem cell populations from the pancreas, salivary gland and sweat gland. Blue crosses, newly introduced primer for
examination of the corresponding gene expression. nd, not determined.
Richter et al. Stem Cell Research & Therapy 2013, 4:78 Page 11 of 13
http://stemcellres.com/content/4/4/78
Richter et al. Stem Cell Research & Therapy 2013, 4:78 Page 12 of 13
http://stemcellres.com/content/4/4/78The proteins stained with continuous presence in pas-
sages 3, 6 and 9 (representative results for passages 3
and 9 in Figure 9) showed less differences between the
individuals or sexes.
To the best of our knowledge we are the first to show a
consistent nestin expression for female and male cells de-
rived from mammary glands over several passages. Our
identification of cells positive for this adult stem cell marker
was supported by the successful detection of cytokeratin
19, a considered marker for mammary stem cells, and the
positive evaluation of various Ki67-synthesizing cells indi-
cating proliferative activity [5,16,22]. Furthermore we
demonstrated that the expression of the mesodermal
protein alpha-smooth muscle actin and of the ectoder-
mal neurofilaments is maintained in culture in male
and female cell populations. We presume this is a result
of a continuous, spontaneous differentiation of an unre-
stricted amount of stem cells.
We would like to emphasize that additional information
about the nestin-positive cell population may foster the
comprehension of MGDC populations with regard to
their stemness. Furthermore, their possible multipotency,
functionality and application shall be examined in in vivo
studies to define the impact on possible therapeutic strat-
egies. For reaching these goals, definitively more human
samples are needed.Conclusion
With the current work we present an easy and reliable
method to isolate nestin-positive stem cells from male
and female mammary tissue. We monitored the forma-
tion of an adherent cell population from acinary mam-
mary structures in vitro and succeeded in establishing
stably proliferating mammary stem cell populations.
During in vitro cultivation the mammary cell popula-
tions exhibit a spontaneous differentiation potential
and give rise to cell types of endodermal, mesodermal
and ectodermal origin. By adapting methods and tech-
niques for the isolation of other gland-derived stem cell
populations we gained comparable nestin-positive,
multipotent stem cell populations from mammary
gland tissue derived from both genders. These results
may have impact for novel clinical strategies for cell-
based therapies.Additional files
Additional file 1: Time-lapse movie showing the in vitro cultivated
mammary gland acinus. The outgrowth of mammary gland cells from
the acinar structure has been documented by time-lapse microscopy.
Continuously observation was done by taking a picture every 7.5 minutes
for a time period of 7 days. Mammary gland cells adhere to the cell
culture plastic, migrate out of the acinar tissue and some single cells start
to proliferate.Additional file 2: Diagrams of fluorescent-activated cell sorting
analysis for one exemplarily shown cell population (MGDC 1).
Representative graphs of flow cytometric analysis of a female mammary
cell population (MGDC 1) in passage 6. The counted events per
fluorescence intensity of the samples (purple area) are referred to that of
the isotype control (green line) for each measurement. PE, phycoerythrin;
PerCP, peridinin chlorophyll protein.
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